Postdoctoral Fellow for the X-ray Spectroscopy Beamline ID26

The ESRF is looking to recruit a Postdoctoral Fellow for the X-ray Spectroscopy Beamline ID26

Closing soon

Closing date: 19 Apr 2021
France | European Synchrotron Radiation Facility
Date posted: 18 Mar 2021
Job type: Academic: postdoc
Disciplines: Optics, lasers & photonics | Electronics & semiconductors

Expired

The European Synchrotron, the ESRF, is an international research centre based in Grenoble, France.

Through its innovative engineering, pioneering scientific vision and a strong commitment from its 700 staff members, the ESRF is recognised as one of the top research facilities worldwide. Its particle accelerator produces intense X-ray beams that are used by thousands of scientists each year for experiments in diverse fields such as biology, medicine, environmental sciences, cultural heritage, materials science, and physics.

Supported by 22 countries, the ESRF is an equal opportunity employer and encourages diversity.

The ESRF beamline ID26 is dedicated to X-ray absorption and emission spectroscopy. We develop advanced X-ray spectroscopy techniques and study the electronic structure and local coordination in systems that are relevant in the applied sciences (materials science, co-ordination (bio)chemistry, (bio)catalysis, mineralogy and earth sciences). The beamline hosts unique instrumentation for advanced X-ray spectroscopies and thus provides state-of-the-art research possibilities. For further information about the instrument, please click here.

We collaborate with theory groups that develop codes for electronic structure calculations for X-ray spectroscopies. You will be encouraged and supported to develop your own research, which should exploit the exceptional beamline capabilities. Your research will concern the element-specific study of the electronic structure of materials. The exact topic of your research will be planned together with your supervisor taking into account your interests and previous experience. You will initiate and participate in collaborative research programmes with universities and research centres.

PhD in physics, chemistry or a related field, obtained less than three years ago.
Previous research related to electronic structure is essential.
Very good skills in instrumentation (e.g. X-rays, in situ cells, spectroscopy) are an asset.
Very good communication skills and willingness to work with multi-disciplinary staff.
Proficiency in English (working language at the ESRF).

We offer a comprehensive benefits package designed to support your quality of life and your installation in the Grenoble area when relocation is needed.

The monthly salary may be complemented by additional allowances upon eligibility (expatriation allowance, etc.).

Expired

Employer profile

European Synchrotron Radiation Facility

France View profile

Employer profiles

AWE

For almost 70 years, AWE has supported the UK Government’s nuclear defence strategy and the Continuous At Sea Deterrent. We also use our nuclear know-how and technical expertise to provide innovative solutions that support the UK’s counter-terrorism and nuclear threat reduction activities

United Kingdom View profile

Cardiff University, School of Physics and Astronomy

Our world-leading research in physics and astrophysics helps us to better understand the physical world around us and informs the education of our students to ensure we produce highly employable graduates

United Kingdom View profile

University of Strathclyde

Research is of central importance in everything we do. It informs our teaching and helps us to make a difference to business, industry and society as a whole. We're in the UK’s top 20 universities for research intensity according to the Times Higher Education’s analysis of REF2014. We are also delighted to have won Times Higher Education University of the Year 2019 – the only university to be awarded the UK-wide award for a second time

United Kingdom View profile

Elekta Limited

Elekta is a leader in precision radiation medicine, committed to ensuring that everyone with cancer in the world has access to – and beneﬁts from – more precise, personalized radiotherapy treatments. Our solutions for cancer care and brain disorders are tailored to target the tumour and protect the patient

United Kingdom View profile